top of page
Menu
Close
Our Story
More About Us
Our Pipeline
Products
News & Events
News Releases
Publications
FAQs
Our Team
Board of Directors
Company Executives
R&D Advisors
Investors
How To Invest
Corporate Profile
Corporate Presentation
Governance
SEDAR Filings
Terms of Use
Privacy Policy
Our Story
More About Us
Our Pipeline
Products
News & Events
News Releases
Publications
FAQs
Our Team
Board of Directors
Company Executives
R&D Advisors
Investors
How To Invest
Corporate Profile
Corporate Presentation
Governance
SEDAR Filings
Terms of Use
Privacy Policy
Publications
Phase 1, First-in-Man Clinical Trial and Pharmacokinetics of Psilocin Mucate (L-130)
October
2024
Pharmaceutical Development Considerations of Psilocin and Its Prodrug Psilocybin: A Comprehensive Review of Published Pharmacokinetic Data
May
2024
An open-label; multicenter, phase 2 study of a food enriched with docosahexaenoic acid in adults with sickle cell disease
June
2023
Clinical effect of SC411 (Altemia TM) on children with sickle cell disease in the scott trial
September 2020
Industry update: What is New in the Field of Therapeutic delivery?
December 2017
Our Story
More About Us
Our Pipeline
Products
News & Events
News Releases
Publications
FAQs
Our Team
Board of Directors
Company Executives
R&D Advisors
Investors
How To Invest
Corporate Profile
Corporate Presentation
Governance
SEDAR Filings
Terms of Use
Privacy Policy
bottom of page
